These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15034739)
1. The role of high-dose chemotherapy in relapsed germ cell tumors. Rick O; Kollmannsberger C; Hartmann JT; Braun T; Siegert W; Bokemeyer C; Beyer J World J Urol; 2004 Apr; 22(1):25-32. PubMed ID: 15034739 [TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients. Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in patients with metastatic or relapsed germ-cell tumours. Rick O; Siegert W; Beyer J Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864 [TBL] [Abstract][Full Text] [Related]
4. Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. Porcu P; Bhatia S; Sharma M; Einhorn LH J Clin Oncol; 2000 Mar; 18(6):1181-6. PubMed ID: 10715286 [TBL] [Abstract][Full Text] [Related]
5. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870 [TBL] [Abstract][Full Text] [Related]
6. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162 [TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors. Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945 [TBL] [Abstract][Full Text] [Related]
8. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [TBL] [Abstract][Full Text] [Related]
9. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy. Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Beyer J; Kingreen D; Krause M; Schleicher J; Schwaner I; Schwella N; Huhn D; Siegert W Cancer; 1997 Jan; 79(1):161-8. PubMed ID: 8988741 [TBL] [Abstract][Full Text] [Related]
14. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318 [TBL] [Abstract][Full Text] [Related]
15. Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours. El-Helw L; Coleman RE Cancer Treat Rev; 2005 May; 31(3):197-209. PubMed ID: 15944049 [TBL] [Abstract][Full Text] [Related]
16. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients. De Giorgi U; Rosti G; Papiani G; Marangolo M Haematologica; 2002 Jan; 87(1):95-104. PubMed ID: 11801470 [TBL] [Abstract][Full Text] [Related]
18. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study]. Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101 [TBL] [Abstract][Full Text] [Related]
20. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. Kollmannsberger C; Rick O; Derigs HG; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer HG; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C J Clin Oncol; 2002 Apr; 20(8):2031-7. PubMed ID: 11956262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]